Search

everythinglearnresearchcommunity

for

Search:↓

Overexpressing PKCepsilon in mice reduces papillomas but increases carcinomas.

Targeting SOX proteins may improve cancer treatment by restoring immune function.

A new method, iSiMPRe, effectively identifies key protein regions in cancer genes, highlighting potential drug targets.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

Targeting ornithine decarboxylase can help prevent skin cancer.

Activating c-Myc in skin causes rapid cell growth and changes, but these effects are reversible.

ETS2 is crucial in squamous cell carcinoma development and could be a therapeutic target.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

SOX4 is crucial for the development of melanoma.

Overexpression of hurpin in mice leads to abnormal skin and higher skin cancer risk.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

The woman had a rare adrenal tumor removed, and she recovered well with no signs of the tumor returning.

Keratinocytes can reverse the effects of the GNAQ oncogene, inhibiting melanoma cell growth.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

Overexpressing COX-2 in mice skin reduces skin tumor development.

Blocking certain proteins in mouse skin can reduce and shrink skin tumors.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Complex basal cell carcinomas need personalized treatment due to unique genetic mutations.

S100A4 promotes aggressive ovarian cancer and is a potential treatment target.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

K10 may not prevent tumors as previously thought and might increase benign tumor risk.

The microenvironment affects the behavior and survival of melanocytes with the GNAQ oncogene in melanoma.

Protein Kinase Cε increases skin sensitivity to UV damage and skin cancer risk.

Overexpressing PKCα in mice skin increases inflammation but doesn't affect tumor growth.

Increased ODC activity leads to skin tumors by recruiting stem cells, not by toxic byproducts.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.